X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
dupilumab (270) 270
atopic dermatitis (160) 160
index medicus (135) 135
dermatology (87) 87
humans (81) 81
asthma (66) 66
placebo (60) 60
double-blind (55) 55
eczema (54) 54
immunology (52) 52
dermatitis (49) 49
skin (49) 49
adults (48) 48
antibodies, monoclonal - therapeutic use (45) 45
allergy (43) 43
efficacy (41) 41
safety (40) 40
dermatitis, atopic - drug therapy (37) 37
management (35) 35
monoclonal antibodies (34) 34
persistent asthma (34) 34
adult (33) 33
omalizumab (33) 33
biologics (30) 30
mepolizumab (30) 30
cytokines (28) 28
il-13 (27) 27
quality of life (27) 27
children (26) 26
lebrikizumab (26) 26
il-4 (24) 24
clinical trials (23) 23
inflammation (22) 22
interleukin 13 (22) 22
patients (22) 22
pharmacology & pharmacy (21) 21
disease (20) 20
moderate (20) 20
biomarkers (19) 19
care and treatment (19) 19
drug therapy (19) 19
interleukin 4 (19) 19
skin diseases (19) 19
filaggrin (18) 18
pruritus (18) 18
treatment outcome (18) 18
benralizumab (17) 17
case report (17) 17
medicine & public health (17) 17
analysis (16) 16
female (16) 16
guidelines (16) 16
male (16) 16
psoriasis (16) 16
tralokinumab (16) 16
allergies (15) 15
expression (15) 15
interleukin-13 (15) 15
pathogenesis (15) 15
severity of illness index (15) 15
cyclosporine (14) 14
dermatitis, atopic - diagnosis (14) 14
inhaled corticosteroids (14) 14
interleukins (14) 14
lymphocytes t (14) 14
reslizumab (14) 14
topical corticosteroids (14) 14
abridged index medicus (13) 13
animals (13) 13
interleukin-4 (13) 13
medicine, research & experimental (13) 13
monoclonal-antibody (13) 13
prevalence (13) 13
quality-of-life (13) 13
tofacitinib (13) 13
immunotherapy (12) 12
review (12) 12
alopecia areata (11) 11
care (11) 11
chronic rhinosinusitis (11) 11
conjunctivitis (11) 11
dermatitis, atopic - immunology (11) 11
dermatitis, atopic - therapy (11) 11
ige (11) 11
immunoglobulin e (11) 11
pediatrics (11) 11
t-cells (11) 11
thymic stromal lymphopoietin (11) 11
trial (11) 11
adult patients (10) 10
antibodies, monoclonal - pharmacology (10) 10
antibodies, monoclonal, humanized - therapeutic use (10) 10
asthma - drug therapy (10) 10
atopic-dermatitis (10) 10
health aspects (10) 10
il, interleukin (10) 10
medical research (10) 10
molecular targeted therapy (10) 10
nemolizumab (10) 10
research (10) 10
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (250) 250
German (12) 12
French (6) 6
Korean (3) 3
Polish (1) 1
Russian (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Dermatological Treatment, ISSN 0954-6634, 2019, pp. 1 - 3
Dupilumab is used for treatment of atopic dermatitis through blockade of IL-4 and IL-13 signaling of the Th2 pathway. Recent case reports have described... 
atopic dermatitis | Dupilumab | rosacea
Journal Article
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, ISSN 0190-9622, 08/2018, Volume 79, Issue 2, pp. E25 - E26
Journal Article
International Journal of Women's Dermatology, ISSN 2352-6475, 08/2019
Journal Article
Journal Article
Annales de Dermatologie et de Venereologie, ISSN 0151-9638, 08/2018, Volume 145, Issue 8-9, pp. 532 - 538
Journal Article
Annals of Allergy, Asthma & Immunology, ISSN 1081-1206, 01/2018, Volume 120, Issue 1, pp. 3 - 4
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 09/2019
Journal Article
Current Therapeutic Research, ISSN 0011-393X, 10/2019, p. 100571
Journal Article
Oncotarget, 2017, Volume 8, Issue 65, pp. 108480 - 108491
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 04/2019, Volume 80, Issue 4, pp. 913 - 921.e9
Baricitinib, an oral selective inhibitor of Janus kinase 1 and Janus kinase 2, modulates proinflammatory cytokine signaling. The efficacy and safety of... 
pruritus | SCORAD | EASI | phase 2 | topical corticosteroids | baricitinib | atopic dermatitis | JAK-STAT signaling | RHEUMATOID-ARTHRITIS | VALIDATION | DERMATOLOGY | TASK-FORCE | DUPILUMAB | TOFACITINIB | Atopic dermatitis | Analysis
Journal Article
Dermatology, ISSN 1018-8665, 05/2019, Volume 235, Issue 3, pp. 187 - 188
Journal Article
Acta dermato-venereologica, ISSN 0001-5555, 06/2019, Volume 99, Issue 7, pp. 675 - 676
Journal Article
The World Allergy Organization journal, ISSN 1939-4551, 08/2019, Volume 12, Issue 8, p. 100050
Chronic rhinosinusitis with nasal polyps (CRSwNP) is a complex upper airway disease affecting up to 11% of the population of Western Europe. In these western... 
Journal Article
JAMA Dermatology, ISSN 2168-6068, 01/2019, Volume 155, Issue 1, pp. 118 - 120
Journal Article
Biologics: Targets and Therapy, ISSN 1177-5475, 2019, Volume 13, pp. 79 - 82
Atopic dermatitis (eczema) is a common chronic disease that is described as severe itching associated with recurrent eczematous lesions. In 2017 the US Food... 
Atopic dermatitis | Adverse effect | Dupilumab | Eczema
Journal Article
Journal of Dermatological Treatment, ISSN 0954-6634, 10/2019, Volume 30, Issue 7, pp. 674 - 676
Background: Several case reports and reviews support a relationship between atopic dermatitis (AD) and infective endocarditis (IE). Here, we present a case of... 
Infective endocarditis | atopic dermatitis | dupilumab | DERMATOLOGY
Journal Article
DERMATOLOGIC THERAPY, ISSN 1396-0296, 03/2019, Volume 32, Issue 2
Atopic dermatitis (AD, atopic eczema) is one of the most common inflammatory skin diseases, with a chronic or relapsing course and strong itching. The... 
new drugs | DUPILUMAB | atopic dermatitis | TOFACITINIB | INHIBITOR | DERMATOLOGY
Journal Article
Expert Opinion on Biological Therapy, ISSN 1471-2598, 07/2018, Volume 18, Issue 7, pp. 747 - 754
Introduction: Severe uncontrolled asthma is by definition refractory to traditional therapies or can be controlled only with therapies that have intolerable... 
reslizumab | IgE | mepolizumab | IL-4 | IL-5 | omalizumab | IL-13 | eosinophil | monoclonal antibody | benralizumab | Asthma | dupilumab | MEDICINE, RESEARCH & EXPERIMENTAL | PLACEBO | EFFICACY | SAFETY | INHALED CORTICOSTEROIDS | PERSISTENT ASTHMA | MONOCLONAL-ANTIBODY | dupilumab;benralizumab | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | DUPILUMAB | DOUBLE-BLIND
Journal Article
ALLERGOLOGIE, ISSN 0344-5062, 10/2018, Volume 41, Issue 10, pp. 490 - 490
Journal Article
Journal of Investigative Dermatology, ISSN 0022-202X, 07/2019, Volume 139, Issue 7, pp. 1480 - 1489
Atopic dermatitis (AD) affects up to 20% of children and adults worldwide. To gain a deeper understanding of the pathophysiology of AD, we conducted a... 
PATHWAYS | PROVIDES INSIGHTS | DEFECTS | LESIONAL SKIN | FILAGGRIN | DUPILUMAB | TRANSCRIPTOMIC ANALYSIS | PATTERNS | EXPRESSION | T-CELLS | DERMATOLOGY
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.